Ready-to-load MHC-I Nanoparticles for High-throughput T cell Screening Studies
The paper describes a ready-to-load virus-like particle (VLP-Open HLA) platform that accommodates up to ~60 HLA (MHC-I) molecules and supports efficient peptide exchange using a pre-loaded placeholder ligand. Using fluorescently tagged HLA nanoparticles, the authors show they can stain antigen-specific CD8+ T cells and use the system for high-throughput screening of novel TCRs, and they demonstrate antigen-specific T cell activation. A key limitation noted is that the work is focused on an in vitro peptide–MHC-I presentation and T-cell engagement framework rather than directly testing clinical outcomes. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,256 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00